Synonym
CP-432; CP 432; CP432; CP-734432; CP 734432; CP734432.
IUPAC/Chemical Name
2-Thiophenecarboxylic acid, 5-(3-((2S)-2-((3R)-3-hydroxy-4-(3-(trifluoromethyl)phenyl)butyl)-5-oxo-1-pyrrolidinyl)propyl)-
InChi Key
JYZXGURJKNAFPT-ZWKOTPCHSA-N
InChi Code
InChI=1S/C23H26F3NO4S/c24-23(25,26)16-4-1-3-15(13-16)14-18(28)8-6-17-7-11-21(29)27(17)12-2-5-19-9-10-20(32-19)22(30)31/h1,3-4,9-10,13,17-18,28H,2,5-8,11-12,14H2,(H,30,31)/t17-,18+/m0/s1
SMILES Code
c1cc(cc(c1)C(F)(F)F)C[C@@H](CC[C@H]2CCC(=O)N2CCCc3ccc(s3)C(=O)O)O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
469.52
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Hu KZ, Ma J, Qiu S, Zheng X, Huang PQ. SmI2-mediated intermolecular coupling
of γ-lactam N-α-radicals with activated alkenes: asymmetric synthesis of
11-hydroxylated analogues of the lead compounds CP-734432 and PF-04475270. J Org
Chem. 2013 Mar 1;78(5):1790-801. doi: 10.1021/jo301277n. Epub 2012 Aug 14. PubMed
PMID: 22853560.
2: Luu KT, Zhang EY, Prasanna G, Xiang C, Anderson S, Fortner J, Vicini P.
Pharmacokinetic-pharmacodynamic and response sensitization modeling of the
intraocular pressure-lowering effect of the EP4 Agonist
5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-
1-yl]propyl}thiophene-2-carboxylate (PF-04475270). J Pharmacol Exp Ther. 2009
Nov;331(2):627-35. doi: 10.1124/jpet.109.157800. Epub 2009 Aug 18. PubMed PMID:
19690190.
3: Prasanna G, Fortner J, Xiang C, Zhang E, Carreiro S, Anderson S, Sartnurak S,
Wu G, Gukasyan H, Niesman M, Nair S, Rui E, Lafontaine J, Almaden CD, Wells P,
Krauss A. Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4
prostaglandin agonist in preclinical models. Exp Eye Res. 2009 Nov;89(5):608-17.
doi: 10.1016/j.exer.2009.05.002. Epub 2009 May 13. PubMed PMID: 19445930.